8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
4.78%
Revenue growth exceeding 1.5x 3088.T's 1.06%. David Dodd would verify if faster growth reflects superior business model.
5.71%
Cost increase while 3088.T reduces costs. John Neff would investigate competitive disadvantage.
0.79%
Gross profit growth below 50% of 3088.T's 5.12%. Michael Burry would check for structural issues.
-3.81%
Margin decline while 3088.T shows 4.01% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-28.16%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
1.48%
Operating expenses growth less than half of 3088.T's 169.63%. David Dodd would verify sustainability.
5.06%
Total costs growth less than half of 3088.T's 28.96%. David Dodd would verify sustainability.
-13.33%
Both companies reducing interest expense. Martin Whitman would check industry trends.
-26.20%
D&A reduction while 3088.T shows 17.66% growth. Joel Greenblatt would examine efficiency.
-3.57%
EBITDA decline while 3088.T shows 26.01% growth. Joel Greenblatt would examine position.
-7.96%
EBITDA margin decline while 3088.T shows 24.68% growth. Joel Greenblatt would examine position.
-1.53%
Both companies show declining income. Martin Whitman would check industry conditions.
-6.02%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-33.24%
Other expenses reduction while 3088.T shows 103.49% growth. Joel Greenblatt would examine advantage.
-4.43%
Pre-tax income decline while 3088.T shows 37.61% growth. Joel Greenblatt would examine position.
-8.79%
Pre-tax margin decline while 3088.T shows 36.16% growth. Joel Greenblatt would examine position.
-4.08%
Tax expense reduction while 3088.T shows 31.28% growth. Joel Greenblatt would examine advantage.
-4.66%
Net income decline while 3088.T shows 41.08% growth. Joel Greenblatt would examine position.
-9.01%
Net margin decline while 3088.T shows 39.60% growth. Joel Greenblatt would examine position.
-4.66%
EPS decline while 3088.T shows 23.71% growth. Joel Greenblatt would examine position.
-4.66%
Diluted EPS decline while 3088.T shows 23.71% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.